These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34398818)

  • 21. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
    PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological profiles and evaluation of parasitaemia by PCR and blood culture in individuals chronically infected by Trypanosoma cruzi treated with benzonidazole.
    Aguiar C; Batista AM; Pavan TB; Almeida EA; Guariento ME; Wanderley JS; Costa SC
    Trop Med Int Health; 2012 Mar; 17(3):368-73. PubMed ID: 22212647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients.
    Zrein M; Granjon E; Gueyffier L; Caillaudeau J; Liehl P; Pottel H; Cardoso CS; Oliveira CDL; de Oliveira LC; Lee TH; Ferreira AM; Ribeiro ALP; Busch MP; Sabino EC
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006226. PubMed ID: 29425201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humans seropositive for Trypanosoma cruzi co-infected with intestinal helminths have higher infectiousness, parasitaemia and Th2-type response in the Argentine Chaco.
    Enriquez GF; Macchiaverna NP; Garbossa G; Quebrada Palacio LP; Ojeda BL; Bua J; Gaspe MS; Cimino R; Gürtler RE; Postan M; Cardinal MV
    Parasit Vectors; 2024 Aug; 17(1):340. PubMed ID: 39135121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exacerbation of HIV viral load simultaneous with asymptomatic reactivation of chronic Chagas' disease.
    Sartori AM; Caiaffa-Filho HH; Bezerra RC; do S Guilherme C; Lopes MH; Shikanai-Yasuda MA
    Am J Trop Med Hyg; 2002 Nov; 67(5):521-3. PubMed ID: 12479555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-infection Trypanosoma cruzi/HIV: systematic review (1980-2010).
    Almeida EA; Ramos Júnior AN; Correia D; Shikanai-Yasuda MA
    Rev Soc Bras Med Trop; 2011; 44(6):762-70. PubMed ID: 22231251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of dehydroepiandrosterone-sulfate (DHEA-S) and benznidazole treatments during acute infection of two different Trypanosoma cruzi strains.
    Santos CD; Loria RM; Oliveira LG; Kuehn CC; Toldo MP; Albuquerque S; do Prado JC
    Immunobiology; 2010 Dec; 215(12):980-6. PubMed ID: 20163889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients.
    Ramírez JC; Cura CI; da Cruz Moreira O; Lages-Silva E; Juiz N; Velázquez E; Ramírez JD; Alberti A; Pavia P; Flores-Chávez MD; Muñoz-Calderón A; Pérez-Morales D; Santalla J; Marcos da Matta Guedes P; Peneau J; Marcet P; Padilla C; Cruz-Robles D; Valencia E; Crisante GE; Greif G; Zulantay I; Costales JA; Alvarez-Martínez M; Martínez NE; Villarroel R; Villarroel S; Sánchez Z; Bisio M; Parrado R; Maria da Cunha Galvão L; Jácome da Câmara AC; Espinoza B; Alarcón de Noya B; Puerta C; Riarte A; Diosque P; Sosa-Estani S; Guhl F; Ribeiro I; Aznar C; Britto C; Yadón ZE; Schijman AG
    J Mol Diagn; 2015 Sep; 17(5):605-15. PubMed ID: 26320872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
    Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT
    Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chagas disease in the immunocompromised host.
    Clark EH; Bern C
    Curr Opin Infect Dis; 2024 Oct; 37(5):333-341. PubMed ID: 38963802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benznidazole, itraconazole and their combination in the treatment of acute experimental chagas disease in dogs.
    Cunha ELA; Torchelsen FKVDS; Cunha LM; de Oliveira MT; Fonseca KDS; Vieira PMA; Carneiro CM; de Lana M
    Exp Parasitol; 2019 Sep; 204():107711. PubMed ID: 31254494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep Sequencing to Detect Diversity of Trypanosoma cruzi Infection in Patients Coinfected With Human Immunodeficiency Virus and Chagas Disease.
    Bowman NM; Balasubramanian S; Gilman RH; Parobek C; Calderon M; Waltmann A; Messenger LA; Sanchez L; Bern C; Juliano JJ;
    J Infect Dis; 2022 Jan; 225(2):243-247. PubMed ID: 34240175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières.
    Yun O; Lima MA; Ellman T; Chambi W; Castillo S; Flevaud L; Roddy P; Parreño F; Albajar Viñas P; Palma PP
    PLoS Negl Trop Dis; 2009 Jul; 3(7):e488. PubMed ID: 19582142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial and satellite real time-PCR for detecting T. cruzi DTU II strain in blood and organs of experimentally infected mice presenting different levels of parasite load.
    Ferreira Filho JCR; Braz LMA; Andrino MLA; Yamamoto L; Kanunfre KA; Okay TS
    Exp Parasitol; 2019 May; 200():13-15. PubMed ID: 30904696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benznidazole therapy for Chagas disease in asymptomatic Trypanosoma cruzi -seropositive former blood donors: evaluation of the efficacy of different treatment regimens.
    Antunes AP; Ribeiro AL; Sabino EC; Silveira MF; Oliveira CD; Botelho AC
    Rev Soc Bras Med Trop; 2016; 49(6):713-720. PubMed ID: 28001218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
    Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
    Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of parasite loads in serum and blood samples from patients in acute and chronic phases of Chagas disease.
    Hernández C; Teherán A; Flórez C; Ramírez JD
    Parasitology; 2018 Dec; 145(14):1837-1843. PubMed ID: 29661257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thioridazine aggravates skeletal myositis, systemic and liver inflammation in Trypanosoma cruzi-infected and benznidazole-treated mice.
    Mendonça AAS; Gonçalves-Santos E; Souza-Silva TG; González-Lozano KJ; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD
    Int Immunopharmacol; 2020 Aug; 85():106611. PubMed ID: 32447223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.
    Morillo CA; Waskin H; Sosa-Estani S; Del Carmen Bangher M; Cuneo C; Milesi R; Mallagray M; Apt W; Beloscar J; Gascon J; Molina I; Echeverria LE; Colombo H; Perez-Molina JA; Wyss F; Meeks B; Bonilla LR; Gao P; Wei B; McCarthy M; Yusuf S;
    J Am Coll Cardiol; 2017 Feb; 69(8):939-947. PubMed ID: 28231946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring the parasite load in chronic Chagas disease patients: comparison between blood culture and quantitative real time PCR.
    D'Ávila DA; Galvão LMC; Sousa GR; Britto C; Moreira OC; Chiari E
    PLoS One; 2018; 13(11):e0208133. PubMed ID: 30496249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.